Researchers are not so good at gauging whether a clinical trial will be successful, Stat News reports.

A team led by McGill University's Jonathan Kimmelman asked cancer researchers to predict whether certain clinical trials would make their primary endpoint, Stat News says, noting that the work isn't yet published. It adds that the cancer researchers queried tended to underestimate trials that would meet their endpoints.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.